Literature DB >> 19965582

VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.

Sarada D Tetali1, Madhu S Budamagunta, Catalina Simion, Laura J den Hartigh, Tamás Kálai, Kálmán Hideg, Danny M Hatters, Karl H Weisgraber, John C Voss, John C Rutledge.   

Abstract

Our previous work indicated that apolipoprotein (apo) E4 assumes a more expanded conformation in the postprandial period. The postprandial state is characterized by increased VLDL lipolysis. In this article, we tested the hypothesis that VLDL lipolysis products increase VLDL particle fluidity, which mediates expansion of apoE4 on the VLDL particle. Plasma from healthy subjects was collected before and after a moderately high-fat meal and incubated with nitroxyl-spin labeled apoE. ApoE conformation was examined by electron paramagnetic resonance spectroscopy using targeted spin probes on cysteines introduced in the N-terminal (S76C) and C-terminal (A241C) domains. Further, we synthesized a novel nitroxyl spin-labeled cholesterol analog, which gave insight into lipoprotein particle fluidity. Our data revealed that the order of lipoprotein fluidity was HDL approximately LDL<VLDL<VLDL+lipoprotein lipase. Moreover, the conformation of apoE4 depended on the lipoprotein fraction: VLDL-associated apoE4 had a more linear conformation than apoE4 associated with LDL or HDL. Further, by changing VLDL fluidity, VLDL lipolysis products significantly altered apoE4 into a more expanded conformation. Our studies indicate that after every meal, VLDL fluidity is increased causing apoE4 associated with VLDL to assume a more expanded conformation, potentially enhancing the pathogenicity of apoE4 in vascular tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965582      PMCID: PMC3035491          DOI: 10.1194/jlr.M000406

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  34 in total

Review 1.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

2.  Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.

Authors:  J R Wetterau; L P Aggerbeck; S C Rall; K H Weisgraber
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

3.  Alterations in the physiochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study.

Authors:  I N Gorshkova; M Menschikowski; W Jaross
Journal:  Biochim Biophys Acta       Date:  1996-04-19

4.  A monomeric, biologically active, full-length human apolipoprotein E.

Authors:  Yonghong Zhang; Sheeja Vasudevan; Radiya Sojitrawala; Wentao Zhao; Chunxian Cui; Chao Xu; Daping Fan; Yvonne Newhouse; Reeny Balestra; W Gray Jerome; Karl Weisgraber; Qianqian Li; Jianjun Wang
Journal:  Biochemistry       Date:  2007-08-23       Impact factor: 3.162

5.  A monomeric human apolipoprotein E carboxyl-terminal domain.

Authors:  Daping Fan; Qianqian Li; Leslie Korando; W Gray Jerome; Jianjun Wang
Journal:  Biochemistry       Date:  2004-05-04       Impact factor: 3.162

6.  Effects of polymorphism on the lipid interaction of human apolipoprotein E.

Authors:  Hiroyuki Saito; Padmaja Dhanasekaran; Faye Baldwin; Karl H Weisgraber; Michael C Phillips; Sissel Lund-Katz
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

7.  Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles.

Authors:  Vasanthy Narayanaswami; J Nicholas Maiorano; Padmaja Dhanasekaran; Robert O Ryan; Michael C Phillips; Sissel Lund-Katz; W Sean Davidson
Journal:  J Biol Chem       Date:  2004-01-21       Impact factor: 5.157

Review 8.  Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins.

Authors:  Hiroyuki Saito; Sissel Lund-Katz; Michael C Phillips
Journal:  Prog Lipid Res       Date:  2004-07       Impact factor: 16.195

9.  Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.

Authors:  Katia A Almeida; Roberto Schreiber; Rosângela F Amâncio; Sérgio P Bydlowski; Adriana Debes-Bravo; Jacqueline S Issa; Célia M C Strunz; Raul C Maranhão
Journal:  Clin Chim Acta       Date:  2003-09       Impact factor: 3.786

10.  Changes of membrane fluidity and Na+,K+-ATPase activity during cellular differentiation in the guinea pig epidermis.

Authors:  T Tanaka; T Hidaka; R Ogura; M Sugiyama
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

View more
  10 in total

1.  Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2012-07-03       Impact factor: 3.162

2.  Enhanced binding of apolipoprotein A-I variants associated with hypertriglyceridemia to triglyceride-rich particles.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  Biochemistry       Date:  2011-02-20       Impact factor: 3.162

3.  Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.

Authors:  Sonny Ly; Robin Altman; Jitka Petrlova; Yu Lin; Silvia Hilt; Thomas Huser; Ted A Laurence; John C Voss
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

Review 4.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

5.  Lipotoxic brain microvascular injury is mediated by activating transcription factor 3-dependent inflammatory and oxidative stress pathways.

Authors:  Hnin Hnin Aung; Robin Altman; Tun Nyunt; Jeffrey Kim; Saivageethi Nuthikattu; Madhu Budamagunta; John C Voss; Dennis Wilson; John C Rutledge; Amparo C Villablanca
Journal:  J Lipid Res       Date:  2016-04-17       Impact factor: 5.922

6.  Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  JSM Atheroscler       Date:  2017-02-13

7.  Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

Authors:  Kalyani G Bharadwaj; Yaeko Hiyama; Yunying Hu; Lesley Ann Huggins; Rajasekhar Ramakrishnan; Nada A Abumrad; Gerald I Shulman; William S Blaner; Ira J Goldberg
Journal:  J Biol Chem       Date:  2010-09-18       Impact factor: 5.157

Review 8.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

9.  Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2014-06-11       Impact factor: 5.922

10.  Postprandial apoE isoform and conformational changes associated with VLDL lipolysis products modulate monocyte inflammation.

Authors:  Laura J den Hartigh; Robin Altman; Romobia Hutchinson; Jitka Petrlova; Madhu S Budamagunta; Sarada D Tetali; Jens O Lagerstedt; John C Voss; John C Rutledge
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.